Efficacy and safety of vitamin D supplementation in patients with chronic lymphocytic leukemia

Journal Title: Advances in Hygiene and Experimental Medicine - Year 2016, Vol 70, Issue

Abstract

Background: Vitamin D (VD) deficiency in chronic lymphocytic leukemia (CLL) is associated with inferior prognosis, shorter time to treatment and worse overall survival. VD deficiency is the first potentially modifiable prognostic factor in CLL. Currently, however, there is a lack of studies concerning VD supplementation in CLL patients.Aim: To evaluate the efficacy and safety of VD supplementation in patients with CLL. Methods: A 6-month interventional study was conducted in CLL patients with lower serum 25-OH-D3 concentrations (< 30 ng/ml) than currently recommended. Patients with VD insufficiency (20-30 ng/ml) received 2000 IU of cholecalciferol/day, patients with moderate deficiency (10-19.9 ng/ml) received 4000 IU/day, and patients with severe VD deficiency (<10 ng/ml) received 6000 IU/day. Results: In the analyzed group of 13 CLL subjects, only 1 patient had a VD level within the optimal range (30-80 ng/ml), 7 had an insufficient concentration, 4 had moderate deficiency, and 1 had severe deficiency. Secondary hyperparathyroidism was diagnosed in 4 subjects. Cholecalciferol supplementation (mean dose of 3384 ± 1211 IU) was followed by a significant increase in 25-OH-D3 concentration (from 17.3 ± 5.8 to 41.4 ± 17.5 ng/ml; p<0.05) and decrease in PTH (p<0.05). Five patients did not achieve the recommended 25-OH-D3 concentration. Calcium level remained unchanged and no patients developed hypercalcemia.Conclusions: VD replenishment is safe and can be effectively achieved by means of the employed cholecalciferol dosage in the majority of patients. However, some subjects may require higher doses to obtain the optimal level and immune function.

Authors and Affiliations

Marcin Kubeczko, Elżbieta Nowara, Wojciech Spychałowicz, Kamil Wdowiak, Anna Bednarek, Dobromiła Karwasiecka, Jerzy Chudek

Keywords

Related Articles

Long-term consumption of fish oil partially protects brain tissue from age-related neurodegeneration

The purpose of this study was to determine the effect of fish oil supplementation on aging in the cerebral cortex, hippocampus and cerebellum of rats. Results of biochemical and histological analyses of brain tissue coll...

Rola profilowania genowego z zastosowaniem macierzy DNA w diagnostyce, określaniu rokowania i odpowiedzi na leczenie w raku jelita grubego

Rak jelita grubego to najczęstszy nowotwór przewodu pokarmowego. Nowotwór ten rozpatrywany jest jako biologiczny model kancerogenezy, w którego przemianie od wczesnego do późnego gruczolaka, a następnie do późnego raka...

Antygeny układu grupowego Duffy: budowa, właściwości serologiczne i funkcja

Antygeny układu grupowego Duffy (Fy) są umiejscowione na glikoproteinie, która siedmiokrotnie przenika przez błonę komórkową i jest obecna na powierzchni krwinek czerwonych i komórek śródbłonka niektórych narządów. Białk...

Download PDF file
  • EP ID EP220688
  • DOI -
  • Views 155
  • Downloads 0

How To Cite

Marcin Kubeczko, Elżbieta Nowara, Wojciech Spychałowicz, Kamil Wdowiak, Anna Bednarek, Dobromiła Karwasiecka, Jerzy Chudek (2016). Efficacy and safety of vitamin D supplementation in patients with chronic lymphocytic leukemia. Advances in Hygiene and Experimental Medicine, 70(), 534-541. https://europub.co.uk/articles/-A-220688